BPP 9a is a proline-rich sequence with characteristic structural rigidity enabling stable conformational states. The motif supports receptor-interface modeling and surface-binding analysis. Its physicochemical properties lend themselves to biophysical characterization. Applications include inhibitory motif studies, peptide folding evaluation, and ligand-target exploration.
CAT No: B08011
CAS No:35115-60-7
Synonyms/Alias:TEPROTIDE;35115-60-7;Angiotensin Converting Enzyme Inhibitor;Tepromide;Teprotido;Teprotidum;teprotida;angiotensin-converting enzyme inhibitor;Teprotidum [INN-Latin];SQ 20881;SQ-20881;Teprotido [INN-Spanish];C3E5QBF1R6;Teprotide [USAN:INN:BAN];CCRIS 9333;TEPROTIDE [INN];Teprotide (USAN/INN);TEPROTIDE [USAN];TEPROTIDE [MART.];SO-20881;5-Oxo-L-prolyl-L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L-proline;CHEBI:9444;CHEMBL408983;(2S)-1-[(2S)-1-[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid;DTXSID301029698;SO 20881;Teprotidum (INN-Latin);Teprotido (INN-Spanish);TEPROTIDE (MART.);Bradykinin potentiator B, 2-L-tryptophan-3-de-L-leucine-4-de-L-proline-8-L-glutamine-;Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro;(2S)-1-[(2S)-1-[(2S,3S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-5-guanidino-2-[[(2S)-1-[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxo-pentanoyl]amino]-3-methyl-pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid;BPP-9a;AC1L9EJT;UNII-C3E5QBF1R6;Bradykinin Potentiating Peptide 9a;Bradykinin-Potentiating Peptide 9a;(2S)-1-((2S)-1-((2S,3S)-2-(((2S)-5-amino-2-(((2S)-1-((2S)-5-guanidino-2-(((2S)-1-((2S)-3-(1H-indol-3-yl)-2-(((2S)-5-oxopyrrolidine-2-carbonyl)amino)propanoyl)pyrrolidine-2-carbonyl)amino)pentanoyl)pyrrolidine-2-carbonyl)amino)-5-oxo-pentanoyl)amino)-3-methyl-pentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid;Peptide 9a, Bradykinin-Potentiating;Nonapeptide Converting Enzyme Inhibitor;Nonapeptide-Converting Enzyme Inhibitor;Enzyme Inhibitor, Nonapeptide-Converting;SCHEMBL613757;SCHEMBL11855843;DTXCID601514903;HY-P2366;MFCD00076208;FB108627;CS-0133127;NS00125817;D06076;G77853;BPP 9a Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH;Q7701390;Angiotensin Converting Enzyme Inhibitor, >=95% (TLC);Pyroglutamyl-tryptophyl-prolyl-arginyl-prolyl-glutaminyl-isoleucyl-prolyl-proline;L-Pyroglutamyl-L-tryptophyl-L-prolyl-L-arginyl-L-prolyl-L-glutaminyl-L-isoleucyl-L-prolyl-L-proline;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More